PLYMOUTH
MEETING, Pa., April 29,
2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a
biotechnology company focused on developing and commercializing DNA
medicines to help treat and protect people from HPV-related
diseases, cancer, and infectious diseases, today announced
that management will participate in the following investor
conferences during the month of May:
The Citizens JMP Life Sciences Conference
Date:
Tuesday, May 14, 2024
Time: 11:30 AM ET
Presenter: Dr. Jacqueline Shea,
President & CEO
Format: Fireside Chat
RBC Capital Markets 2024 Global Healthcare
Conference
Date: Wednesday, May 15,
2024
Time: 10:00 AM ET
Presenter: Dr. Jacqueline Shea,
President & CEO
Format: Fireside Chat
H.C. Wainwright 2nd Annual BioConnect Investor Conference at
NASDAQ
Date: Monday, May 20,
2024
Time: 12:30 PM ET
Presenter: Dr. Jacqueline Shea,
President & CEO
Format: Fireside Chat
During the conferences, Dr. Shea and members of INOVIO's
management team will conduct one-on-one meetings with registered
investors.
Webcasts of the fireside chats will be available on the INOVIO
Investor Relations Events page at
https://ir.inovio.com/events-and-presentations/default.aspx.
Replays of the webcasts will be available for 90 days after the
date of the presentation.
About INOVIO
INOVIO is a biotechnology company focused
on developing and commercializing DNA medicines to help treat and
protect people from HPV-related diseases, cancer, and infectious
diseases. INOVIO's technology optimizes the design and delivery of
innovative DNA medicines that teach the body to manufacture its own
disease-fighting tools. For more information, visit
www.inovio.com.
Contacts
Media: Jennie
Willson (267) 429-8567 jennie.willson@inovio.com
Investors: Thomas Hong (267)
440-4298 thomas.hong@inovio.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/inovio-to-participate-in-upcoming-investor-conferences-in-may-302129665.html
SOURCE INOVIO Pharmaceuticals, Inc.